![Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis | American Society of Nephrology Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis | American Society of Nephrology](https://cjasn.asnjournals.org/content/clinjasn/17/5/693/F1.large.jpg)
Apixaban versus Warfarin for Treatment of Venous Thromboembolism in Patients Receiving Long-Term Dialysis | American Society of Nephrology
![Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study | Journal of the American Heart Association Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/47819175-e29b-4257-812f-a3370e7dbe11/jah34898-fig-0001.png)
Rates of Potentially Inappropriate Dosing of Direct‐Acting Oral Anticoagulants and Associations With Geriatric Conditions Among Older Patients With Atrial Fibrillation: The SAGE‐AF Study | Journal of the American Heart Association
![Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review](https://assets.cureus.com/uploads/figure/file/353941/lightbox_09ea24d0b01e11ec837f690cbae5788d-Picture2.png)
Cureus | Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review
![Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - ScienceDirect Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870309009454-gr2.jpg)
Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale - ScienceDirect
Apixaban Concentration with and without Coadministration of Carbamazepine: A Case with No Apparent Interaction
![Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial - The Lancet Neurology Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/b56cba48-4e69-4e49-833e-3423d6bb0e5c/gr1.gif)
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial - The Lancet Neurology
Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach | PLOS ONE
![Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study - Journal of Stroke and Cerebrovascular Diseases Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study - Journal of Stroke and Cerebrovascular Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d82f3a5b-0738-46e6-84c9-b629af859b3c/gr1.jpg)
Secondary stroke prevention with apixaban in nonvalvular atrial fibrillation: A subgroup analysis of the STANDARD study - Journal of Stroke and Cerebrovascular Diseases
![Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - Journal of Cardiology Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/159cb89d-11b1-4a0d-8927-e72997da9cd5/gr1.jpg)